Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required) under Funding Opportunity Number RFA-DK-26-308. This initiative aims to complete enrollment in the Liver Cirrhosis Network Cohort and the RESCU clinical studies, specifically targeting current grant recipients of RFA-DK-20-003, with a limit of one application per institution. The program is crucial for advancing clinical and translational research on cirrhosis treatments and outcomes, with the NIH planning to commit approximately $3.3 million in FY 2026 for up to ten awards, each with a maximum project period of five years. Applications are due by March 6, 2026, and interested parties can contact the Division of Digestive Diseases and Nutrition at NIDDK_DDN@nih.gov for further information.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.This is a Limited Competition funding opportunity intended to fund organizations who are grant recipients of RFA-DK-20-003.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.